Literature DB >> 26782047

Cyto-Insectotoxin 1a from Lachesana tarabaevi Spider Venom Inhibits Chlamydia trachomatis Infection.

Nadezhda F Polina1, Marina M Shkarupeta1, Anna S Popenko1, Alexander A Vassilevski2, Sergey A Kozlov2, Eugene V Grishin2, Vassili N Lazarev3,4, Vadim M Govorun1,2,5.   

Abstract

Venom of the ant spider Lachesana tarabaevi contains a wide variety of antimicrobial peptides. Among them, a special place belongs to cyto-insectotoxins, a class of cytolytic molecules showing equally potent antimicrobial and insecticidal effects. We tested one of them, CIT 1a, for ability to suppress Chlamydia trachomatis infection. HEK293 cells were transfected with plasmid vectors harboring the cit 1a gene. Controlled expression of the transgene led to a significant decrease in C. trachomatis viability inside the infected cells. Using proteomic and transcriptomic approaches, we found alterations in protein expression patterns and identified differentially expressed genes in transfected cells.

Entities:  

Keywords:  Antimicrobial peptide; Cytolytic peptide; Gene therapy; Infectious disease; Proteomics; Transcriptome

Year:  2012        PMID: 26782047     DOI: 10.1007/s12602-012-9108-9

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  29 in total

Review 1.  Antimicrobial resistance in sexually transmitted infections in the developed world: implications for rational treatment.

Authors:  Catherine A Ison
Journal:  Curr Opin Infect Dis       Date:  2012-02       Impact factor: 4.915

Review 2.  New insights into a persistent problem -- chlamydial infections.

Authors:  Richard P Morrison
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 3.  Emerging themes and therapeutic prospects for anti-infective peptides.

Authors:  Nannette Y Yount; Michael R Yeaman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012       Impact factor: 13.820

4.  A model for antimicrobial gene therapy: demonstration of human beta-defensin 2 antimicrobial activities in vivo.

Authors:  George T-J Huang; Hai-Bo Zhang; Daniel Kim; Lide Liu; Tomas Ganz
Journal:  Hum Gene Ther       Date:  2002-11-20       Impact factor: 5.695

Review 5.  Therapeutic approaches to Chlamydia infections.

Authors:  Laurence Senn; Margaret R Hammerschlag; Gilbert Greub
Journal:  Expert Opin Pharmacother       Date:  2005-10       Impact factor: 3.889

6.  High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China.

Authors:  Bin Cao; Chun-Jiang Zhao; Yu-Dong Yin; Fei Zhao; Shu-Fan Song; Lu Bai; Jian-Zhong Zhang; Ying-Mei Liu; Yu-Yu Zhang; Hui Wang; Chen Wang
Journal:  Clin Infect Dis       Date:  2010-07-15       Impact factor: 9.079

7.  Effect of induced expression of an antimicrobial peptide melittin on Chlamydia trachomatis and Mycoplasma hominis infections in vivo.

Authors:  V N Lazarev; M M Shkarupeta; G A Titova; E S Kostrjukova; T A Akopian; V M Govorun
Journal:  Biochem Biophys Res Commun       Date:  2005-10-17       Impact factor: 3.575

8.  Induced expression of melittin, an antimicrobial peptide, inhibits infection by Chlamydia trachomatis and Mycoplasma hominis in a HeLa cell line.

Authors:  V N Lazarev; T M Parfenova; S K Gularyan; O Yu Misyurina; T A Akopian; V M Govorun
Journal:  Int J Antimicrob Agents       Date:  2002-02       Impact factor: 5.283

9.  Susceptibility of Chlamydia trachomatis to protegrins and defensins.

Authors:  B Yasin; S S Harwig; R I Lehrer; E A Wagar
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

Review 10.  Antibiotic consumption and link to resistance.

Authors:  H Goossens
Journal:  Clin Microbiol Infect       Date:  2009-04       Impact factor: 8.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.